Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim versus pegfilgrastim for fever and immune deficiency
IRCT20130812014333N80Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of filgrastim and pegfilgrastim in immunocompromise and ischemic stroke, sponsored by Kermanshah University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
filgrastimpegfilgrastim
03
Conditions
immunocompromiseischemic stroke
Beyond the preview
Go deeper on IRCT20130812014333N80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N80.